Evogene Ltd. (EVGN) has a market capitalization of $7.07M and trades at $0.81. The 52-week range is 0.72-2.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-1.08, annual revenue of $3.85M.
The stock has a beta of 0.95, operates in the Healthcare sector.
